![Roger R. Blunt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roger R. Blunt
Direktor/Vorstandsmitglied bei Fyodor Biotechnologies, Inc.
Profil
Roger R.
Blunt currently works at Fyodor Biotechnologies, Inc., as Non-Executive Director.
Aktive Positionen von Roger R. Blunt
Unternehmen | Position | Beginn |
---|---|---|
Fyodor Biotechnologies, Inc.
![]() Fyodor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Fyodor Biotechnologies, Inc.
![]() Fyodor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation. | Health Technology |